Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This research study is studying the combination of venetoclax and chemotherapy as a possible
treatment for acute myelogenous leukemia (AML).
The drugs involved in this study are:
- Venetoclax
- Daunorubicin
- Cytarabine